Life after ibrutinib? A new unmet need in CLL
- PMID: 25814485
- DOI: 10.1182/blood-2015-02-622472
Life after ibrutinib? A new unmet need in CLL
Abstract
In this issue of Blood, Jain et al reported on the poor outcomes of patients with chronic lymphocytic leukemia (CLL) after the discontinuation of ibrutinib.
Comment on
-
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib.Blood. 2015 Mar 26;125(13):2062-7. doi: 10.1182/blood-2014-09-603670. Epub 2015 Jan 8. Blood. 2015. PMID: 25573991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources